By 2033, the global vessel-sealing devices market is expected to hit USD 3,896.44 million, expanding at a CAGR of 9%. In 2023, the market is estimated at USD 1,645.90 million.
Domains including laparoscopic surgery, neck surgery, and axillary dissection, have demonstrated that vessel-sealing devices are more effective to occlude the blood vessels. This is expected to drive the market for vessel-sealing devices.
Using advanced technologies such as advanced bipolar and ultrasonic energy devices has improved surgeon safety and efficiency by reducing blood loss and operative time. As a result of such advancements in surgical devices and FDA approvals for vessel-sealing devices, the market for vessel-sealing devices is expected to grow during the forecast period.
Key drivers of this market include product developments, surgical procedures, and the preference for minimally invasive surgery. As one of the top manufacturers of vessel-sealing devices. Medtronic, for example, records sales of USD 5.4 million in its surgical innovation portfolio. This includes advanced energy, stapling, and visualization devices.
The booming healthcare sector is another prominent factor driving the market growth. Due to the growing incidence of infectious and non-communicable diseases, the healthcare sector is being strengthened to improve healthcare outcomes. As a result of favorable government investment in the healthcare sector, vessel-sealing devices are becoming increasingly popular.
The challenges that are likely to hinder vessel-sealing device market growth during the forecasting period are complications related to vessel-sealing devices such as bleeding. Also, expensive surgeries are unaffordable for low and middle-income countries. It is, however, the high cost of the products that are hampering the growth of the market.
| Attribute | Details |
|---|---|
| Market Size (2023) | USD 1,645.90 million |
| Market Size (2033) | USD 3,896.44 million |
| Market CAGR (2023 to 2033) | 9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Historical CAGR | 8.1% |
|---|---|
| Historical Market Value (2022) | USD 1,509.17 million |
| Forecast CAGR | 9% |
Vessel-sealing devises Market:
| Attributes | Vessel-sealing devises Market |
|---|---|
| CAGR (2023 to 2033) | 9% |
| Market Value (2023) | USD 1,645.45 million |
| Market Value (2033) | USD 3,896.44 million |
| Growth Factor | Advancements in vessel sealing devices with minimally invasive surgeries. |
| Opportunity | Medical companies are expanding research into proprietary low-power technology |
| Key Trends | Widespread product adoption in laparoscopic surgeries as they are minimally invasive. |
Surgical Navigation System Market:
| Attributes | Surgical Navigation System Market |
|---|---|
| CAGR (2023 to 2033) | 6.2% |
| Market Value (2023) | USD 1,125.90 million |
| Market Value (2033) | USD 2,054.69 million |
| Growth Factor | Increase in the occurrence of target conditions like brain tumors, osteoarthritis, ENT disorders |
| Opportunity | Advancement in new products and technology |
| Key Trends | The rise in demand for safer and less invasive surgeries |
Oculoplastic Surgery Market:
| Attributes | Oculoplastic Surgery Market |
|---|---|
| CAGR (2023 to 2033) | 5.72% |
| Market Value (2023) | USD 9.38 billion |
| Market Value (2033) | USD 16.35 billion |
| Growth Factor | Rising concerns related to body aesthetics, same-day procedure, and quick recovery time |
| Opportunity | Growing aesthetic users, and increasing receptivity to new aesthetic procedures |
| Key Trends | Rising prevalence of diabetic retinopathy. |
Principal Consultant
Rise in Surgical Procedures
Vessel-sealing devices market growth is primarily influenced by increasing surgeries, which are primarily the result of accidents, sports-related injuries, and cardiac surgeries caused by a high prevalence of cardiovascular diseases and other chronic conditions that require surgery.
Increasing preference for minimally invasive surgeries is expected to drive the market demand for vessel-sealing devices. To cut tissues and control hemostasis, minimally invasive surgery requires an energy source.
According to cohort research by Kyle H. Sheetz, robotic surgical tools have also revolutionized how minimally invasive surgery is performed, and surgeons are accepting them more and more. From 1.8% in 2012 to 15.1% in 2018, a rise of 8.4% in 2019 has been recorded. Consequently, an increasing number of surgical procedures worldwide is likely to drive growth in the market for vessel-sealing devices during the forecast period.
Drawbacks of Vessel-sealing Devices
The market growth for vessel-sealing devices is likely to limit growth due to lateral thermal energy spread that can harm the bowel, ureters, and nerves. An article written by Shosaburo Oyama in 2020 states that LigaSure can cause complications during surgery due to lateral energy spread that damages 2 mm of tissue.
Since large, dense tissues cannot fit between the blades of LigaSure, they cannot clamp essential blood vessels and nerves. During routine procedures, such as significant organ bleeding, it would be difficult to use this device. Moreover, generator failure can exacerbate blood loss and damage to vessels.
Lack of training to use these devices by surgeons and lack of evaluation of how safely these devices are used increases the risk of damaging nearby structures. Patients and medical staff can be injured during vessel sealing.
The market is expected to be hampered due to complications appearing in using vessel-sealing devices because bipolar devices are more expensive than other devices, additionally, equipment disposal incurs additional costs.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Innovative Flat Coagulation may hold the Promise of Fitting Dense Tissue Between the Blades of a Device
Blood vessel-sealing devices have become widely publicized as very effective hemostatic devices for preventing bleeding. However, squeezing large and dense tissues between the blades of the devices is challenging.
Therefore, companies such as Medtronic plc are taking advantage of the opportunity in this challenge to improve their vessel-sealing system. With LigaSureTM, a novel method of hemostasis called flat coagulation. Companies are increasing their research and development capabilities which is useful for pelvic manipulation in rectal surgery.
Intact Patch Repairs Internal Blood Vessel Defects with Electrically Activated Glue
In the vessel-sealing devices market, medical technology companies are developing devices that seal blood vessels quickly and less invasively. Nanyang Technological University (NTU) researchers are developing an electrically activated glue patch that can be applied via a minimally invasive balloon catheter that is gaining recognition.
These devices hold the promising potential to replace the need for open or keyhole surgery to patch up or stitch together internal blood vessel defects. Companies in the vessel-sealing devices market are focusing on creating glue patches that can be guided into the body to the tear site. These patches can be activated with retractable electrodes to securely hold them shut within seconds at the site.
Invasive Surgery can be Facilitated with Technologically Advanced Devices in a Safe, Effective Way
Vessel-sealing devices are becoming increasingly available on the market, catering to an increasing number of patients. Bolder Surgical, a provider of surgical devices and instruments, has introduced the CoolSealTM Vessel-sealing platform for minimally invasive surgery on pediatric patients.
In response to such innovations, med-tech companies are expanding research into proprietary low-power technology, which increases devices available to patients of a wide variety of ages.
An increase in vessel-sealing devices is designed with fine-tipped, dual-action jaws and minimal thermal distribution around critical structures to deliver precise dissection and quick sealing times.
Based on application, the global vessel-sealing device market is segmented into general and laparoscopic surgery. With the leading market share in general surgery, the segment is expected to grow at a CAGR of 4.50% during the forecast period. General surgery covers a wide range of operative techniques to diagnose and treat ailments and injuries.
Increasing patients undergoing surgical procedures, and an increase in the incidence of chronic diseases surge the demand. Moreover, an increase in the demand for inexpensive vessel-sealing devices for general surgery is cited as the reason for the growth of the market.
The most common illnesses found worldwide are cardiovascular diseases, which are the leading causes of death as well. Ischemic heart disease is responsible for 16% of all deaths worldwide, according to the WHO updates for 2020. In 2019, total deaths related to ischemic heart disease increased by over 2 million to 8.9 million, a sizable increase since 2000. These conditions result in thousands of general surgeries, which helps the segment grow.
Based on end users, the global vessel sealing device market is categorized into hospitals, specialty clinics, and ambulatory surgical centers. In the forecast period, hospitals and specialty clinics are expected to account for the biggest share of the market and register a CAGR of 4.86%. Since hospitals perform a significant amount of surgeries, they hold a large share of the vessel-sealing device market.
As surgical procedures become more common in hospitals and clinics, vessel sealing devices are used more frequently to reduce blood loss, infection rates, and operating time. Due to the ease of handling emergencies during surgical procedures or post-operative complications, most laparoscopic surgical procedures are performed in hospitals. It is therefore crucial to consider how vessel sealing devices are used in surgical procedures; as a result, the market for these devices is expected to grow over the next few years.
North America is the leading region in the vessel sealing market and is projected to offer a substantial absolute dollar opportunity with a CAGR of 4.5%.
As a result of the presence of key pharmaceutical companies such as Medtronic, Olympus Corporation, B. Braun Melsungen AG, Medical Devices Business Services, Inc. (Johnson & Johnson), Erbe Elektromedizin GmbH, Bowa Medical, OmniGuide Holdings, Inc., Intuitive Surgical, Bolder Surgical LLC, and KLS Martin Group in the region, it is expected to retain its dominant share in the global market.
| Country | Insights |
|---|---|
| United States | Rising chronic diseases in the USA, FDA approval of advanced medical devices, and the increasing use of surgical interventions by the American public are expected to drive market growth. Furthermore, minimally invasive surgery is on the rise throughout the country. According to the American Heart Association Research Report 2018, one out of seven deaths worldwide is caused by heart disease. Because of the increased frequency of causes of death, vessel-sealing devices will be in increasing demand in the USA. |
| Germany | Increasing frequencies of various diseases increased surgical procedures, and a growing geriatric population in the country have led to a substantial number of foreign firms creating goods in Germany. Moreover, growing organ transplants are expected to boost the market for vessel-sealing devices. During nephrectomy and hepatectomy procedures for organ donation, vascular sealing has proven to be a successful method for achieving hemostasis. This is done by sealing both the venous and arterial branches of the donor and recipient's principal renal vessels. Therefore, the aforementioned factors are driving the growth of the German market. |
| Japan | The Japanese healthcare market has experienced rapid growth over the past few years. Also, the nation has an extensive network of hospitals and a highly developed healthcare infrastructure in the Asia Pacific region. Additionally, it is expected that an increase in surgical procedures may increase demand for several procedures, resulting in a greater demand for vessel sealing devices. There are very few studies that compare the efficacy and safety of vessel-sealing devices to thoracoscopic lobectomy operations in humans. Even though vessel-sealing devices are commonly used in Japan for a variety of surgical procedures, including thoracoscopic surgery. Disposable vessel-sealing tools such as EnSeal, LigaSure, and Harmonic are the most widely used in Japan. |
Added an Edge to Vessel-sealing Devices Dynamics: Emerging Companies
New market players in the vessel-sealing devices market are gaining a strategic edge. This is by introducing enhanced products, leveraging technological advances, and gaining a competitive advantage in the process. To remain competitive, these firms continuously invest in research and development activities to meet consumer preferences as well as end-use industry requirements.
Due to the lack of strong entry barriers into the global vessel-sealing devices market, efforts are being made to strengthen their foothold in the industry and domestic players are expected to enter the global market is increasing. This is not only to enhance their visibility within the forum but also to aid in its expansion.
During surgeries, technological advancements in medical devices are increasing the demand for reliable and efficient technologies. This is to reduce blood loss and infection rates and shorten operative times, driving market growth.
For instance, Bolder Surgical, a provider of surgical instruments and devices, launched the CoolSeal Vessel-sealing platform in December 2020, enabling minimally invasive surgery for pediatric patients. There has been an increase in hospitals investing in surgical instruments as well as government initiatives that are boosting the market.
Key players operating the global vessel-sealing devices market include:
Key Developments
Among the key activities undertaken by market players are product launches, expansions, and expansions of their distribution networks, as well as establishing global footprints through subsidiaries and partnerships. Key activities for market players include portfolio diversification, mergers, and acquisitions.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2023 |
| Market Analysis | USD million for Value and MT for Volume |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Chile, Peru, Germany, United Kingdom, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Türkiye |
| Key Segments Covered | Application, End User, Region |
| Key Companies Profiled | Medtronic PLC; B Braun Melsungen AG; Erbe Medical India Pvt. Ltd; Olympus Corporation; Ethicon US LLC (Johnson & Johnson); Boston Scientific Corporation; BOWA-electronic GmbH & Co. KG; OmniGuide Holdings Inc.; CONMED Corporation; Bolder Surgical Holdings Inc |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
North America dominates the market for vessel-sealing devices.
The vessel-sealing devices market is expected to increase at a CAGR of 9% over the forecast period.
The global vessel-sealing devices market is highly fragmented with the presence of various leading and emerging players including Medtronic PLC and Olympus Corporation and others.
The vessel-sealing devices market is expected to reach USD 1,645.90 million by 2023.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 5.1. General Surgery 5.2. Laparoscopic Surgery 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 6.1. Generators 6.2. Instruments 6.3. Accessories 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use 7.1. Hospitals & Specialty Clinics 7.2. Ambulatory Surgical Centres 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. Asia Pacific 8.5. Middle East and Africa (MEA) 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Key Countries Market Analysis 15. Market Structure Analysis 16. Competition Analysis 16.1. Medtronic 16.2. Olympus Corporation 16.3. B. Braun Melsungen AG 16.4. Johnson & Johnson 16.5. Erbe Elektromedizin GmbH 16.6. Bowa Medical 16.7. OmniGuide Holdings, Inc. 16.8. Intuitive Surgical 16.9. Hologic's 16.10. KLS Martin Group 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports
Vessel-sealing Devices Market
